IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)
$33.81 -0.06 (-0.1771%)
Analysed IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) News Sources
VRDN Stock Rises 6.3% in a Week: Here's What You Need to Know
01-07-2026
yahoo.com
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare
02-07-2026
yahoo.com
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data
02-07-2026
yahoo.com
Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT
02-07-2026
yahoo.com
UTHR Strengthens Regenerative Medicine Platform With Thymmune Deal
03-07-2026
yahoo.com
Reasons Why Investors Should Consider Betting on Neurocrine Stock
06-07-2026
yahoo.com
TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia
07-07-2026
yahoo.com
AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study
07-07-2026
yahoo.com
Is Immunocore Holdings (IMCR) Undervalued After Its Recent Share Price Rebound?
09-07-2026
yahoo.com
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
30-07-2026
yahoo.com
What is the current price of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The current price of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is $33.81.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) since the previous trading day is $-0.06.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) since the previous trading day is -0.1771%.
What is the most recent average sentiment score for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The most recent average sentiment score for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)?
The most recent sentiment for IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ) is .
SEC-8K** Filing Available For IMMUNOCORE HOLDINGS PLC-ADR (IMCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.